{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:36:19Z","timestamp":1787150179564,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00417-026-07242-z","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:35:59Z","timestamp":1776501359000},"page":"2529-2536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frequency-dependent risk of steroid-induced ocular hypertension"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6467-3489","authenticated-orcid":false,"given":"Injeong","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2886-3048","authenticated-orcid":false,"given":"Heesuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4662-5252","authenticated-orcid":false,"given":"Jin-Ok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8373-9999","authenticated-orcid":false,"given":"Chan Yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3015-2502","authenticated-orcid":false,"given":"Wungrak","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"7242_CR1","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1097\/iae.0000000000001369","volume":"37","author":"C MalclesA, Dot","year":"2017","unstructured":"Malcles A, Dot C, Voirin N, Vie AL, Agard E, Bellocq D, Denis P, Kodjikian L (2017) Safety of intravitreal dexamethasone implant (OZURDEX): the SAFODEX study. Incidence and risk factors of ocular hypertension. Retina (Philadelphia Pa) 37:1352\u20131359. https:\/\/doi.org\/10.1097\/iae.0000000000001369","journal-title":"Retina (Philadelphia Pa)"},{"key":"7242_CR2","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","volume":"121","author":"DS Boyer","year":"2014","unstructured":"Boyer DS, Yoon YH, Belfort R Jr., Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H, Hashad Y, Whitcup SM (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121:1904\u20131914. https:\/\/doi.org\/10.1016\/j.ophtha.2014.04.024","journal-title":"Ophthalmology"},{"key":"7242_CR3","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","volume":"117","author":"JA Haller","year":"2010","unstructured":"Haller JA, Bandello F, Belfort R Jr., Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134\u20131146e1133. https:\/\/doi.org\/10.1016\/j.ophtha.2010.03.032","journal-title":"Ophthalmology"},{"key":"7242_CR4","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.18240\/ijo.2021.10.15","volume":"14","author":"P Neves","year":"2021","unstructured":"Neves P, Ornelas M, Matias I (2021) Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes. Int J Ophthalmol 14:1571\u20131580","journal-title":"Int J Ophthalmol"},{"key":"7242_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1167\/iovs.10-5285","volume":"52","author":"JE Chang-Lin","year":"2011","unstructured":"Chang-Lin JE, Attar M, Acheampong AA (2011) Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 52:80\u201386","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7242_CR6","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00417-018-4016-7","volume":"256","author":"J Blanc","year":"2018","unstructured":"Blanc J, Deschasse C, Kodjikian L, Dot C, Bron AM, Creuzot-Garcher C (2018) Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience. Graefes Arch Clin Exp Ophthalmol 256:1441\u20131448. https:\/\/doi.org\/10.1007\/s00417-018-4016-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7242_CR7","first-page":"458","volume":"12","author":"AF Clark","year":"2003","unstructured":"Clark AF, Yorio T (2003) Steroids, ocular hypertension, and glaucoma. J Glaucoma 12:458\u2013462","journal-title":"J Glaucoma"},{"key":"7242_CR8","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1136\/bjophthalmol-2018-312958","volume":"103","author":"W Choi","year":"2019","unstructured":"Choi W, Park SE, Kang HG, Byeon SH, Kim SS, Koh HJ, Lee S, Seong GJ, Kim CY, Kim M (2019) Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients. Br J Ophthalmol 103:1380\u20131387. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312958","journal-title":"Br J Ophthalmol"},{"key":"7242_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2147\/OPTH.S148990","volume":"12","author":"S Bahadorani","year":"2018","unstructured":"Bahadorani S, Krambeer C, Wannamaker K, Tie W, Jansen M, Espitia J, Sohn JH, Singer MA (2018) The effects of repeated Ozurdex injections on ocular hypertension. Clin Ophthalmol 12:639\u2013642. https:\/\/doi.org\/10.2147\/OPTH.S148990","journal-title":"Clin Ophthalmol"},{"key":"7242_CR10","doi-asserted-by":"publisher","unstructured":"Pacella E, Loffredo L, Malvasi M, Trovato Battagliola E, Messineo D, Pacella F, Arrico L (2020) Effects of repeated intravitreal injections of dexamethasone implants on intraocular pressure: a 4-year study. Clinical ophthalmology (Auckland, NZ). 14:3611\u20133617. https:\/\/doi.org\/10.2147\/opth.S265691","DOI":"10.2147\/opth.S265691"},{"key":"7242_CR11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","volume":"11","author":"SA Gaballa","year":"2021","unstructured":"Gaballa SA, Kompella UB, Elgarhy O, Alqahtani AM, Pierscionek B, Alany RG, Abdelkader H (2021) Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res 11:866\u2013893. https:\/\/doi.org\/10.1007\/s13346-020-00843-z","journal-title":"Drug Deliv Transl Res"},{"key":"7242_CR12","first-page":"500","volume":"70","author":"B Becker","year":"1963","unstructured":"Becker B, Mills DW (1963) Corticosteroids and intraocular pressure. Archophthalmol 70:500\u2013507","journal-title":"Archophthalmol"},{"key":"7242_CR13","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","volume":"118","author":"JA Haller Jr.","year":"2011","unstructured":"Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM, Ozurdex GSG, Li J (2011) Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal veinocclusion twelve-month study results. Ophthalmology 118:2453\u20132460. https:\/\/doi.org\/10.1016\/j.ophtha.2011.05.014","journal-title":"Ophthalmology"},{"key":"7242_CR14","doi-asserted-by":"publisher","unstructured":"Lim HC, Park SW, Lee JE, Kim SJ, Lee JW (2016) Risk factors and incidence of elevated intraocular pressure after dexamethasone intravitreal implant. J Korean Ophthalmological Soc 57. https:\/\/doi.org\/10.3341\/jkos.2016.57.9.1422","DOI":"10.3341\/jkos.2016.57.9.1422"},{"key":"7242_CR15","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/bjophthalmol-2019-314559","volume":"104","author":"W Choi","year":"2020","unstructured":"Choi W, Bae H, Choi EY, Kim M, Kim EW, Kim C, Kim M, Seong GJ (2020) Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population. Br J Ophthalmol 104:1423\u20131429","journal-title":"Br J ophthalmol"},{"key":"7242_CR16","first-page":"e413","volume":"163","author":"E La Pacella","year":"2012","unstructured":"Pacella E, Pacella F, La Torre G (2012) Testing the effectiveness of intravitreal ranibizumab during 12 months of follow-up in venous occlusion treatment. Clin Ter 163:e413\u2013e422","journal-title":"Clin Ter"},{"key":"7242_CR17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/iae.0000000000001004","volume":"36","author":"RK Maturi","year":"2016","unstructured":"Maturi RK, Pollack A, Uy HS, Varano M, Gomes AM, Li XY, Cui H, Lou J, Hashad Y, Whitcup SM (2016) Intraocular pressure in patients with diabetic macular edema treated with dexamethasone intravitreal implant in the 3-year mead study. Retina 36:1143\u20131152. https:\/\/doi.org\/10.1097\/iae.0000000000001004","journal-title":"Retina"},{"key":"7242_CR18","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/IAE.0000000000001364","volume":"37","author":"EK Chin","year":"2017","unstructured":"Chin EK, Almeida DRP, Velez G, Xu K, Peraire M, Corbella M, Elshatory YM, Kwon YH, Gehrs KM, Boldt HC, Sohn EH, Russell SR, Folk JC, Mahajan VB (2017) Ocular hypertension after intravitreal dexamethasone (OZURDEX) sustained-release implant. Retina 37:1345\u20131351","journal-title":"Retina"},{"key":"7242_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000342160","volume":"229","author":"L Querques","year":"2013","unstructured":"Querques L, Querques G, Lattanzio R, Gigante SR, Del Turco C, Corradetti G, Cascavilla ML, Bandello F (2013) Repeated intravitreal dexamethasone implant (Ozurdex(R)) for retinal vein occlusion. Ophthalmologica 229:21\u201325. https:\/\/doi.org\/10.1159\/000342160","journal-title":"Ophthalmologica"},{"key":"7242_CR20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3349\/ymj.2022.63.9.850","volume":"63","author":"W Choi","year":"2022","unstructured":"Choi W, Kim JD, Bae HW, Kim CY, Seong GJ, Kim M (2022) Axial length as a risk factor for steroid-induced ocular hypertension. Yonsei Med J 63:850\u2013855. https:\/\/doi.org\/10.3349\/ymj.2022.63.9.850","journal-title":"Yonsei Med J"},{"key":"7242_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/01.icu.0000193079.55240.18","volume":"17","author":"R Jones","year":"2006","unstructured":"Jones R 3rd, Rhee DJ (2006) Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 17:163\u2013167. https:\/\/doi.org\/10.1097\/01.icu.0000193079.55240.18","journal-title":"Curr Opin Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07242-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07242-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07242-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:22:38Z","timestamp":1787149358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07242-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7242"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07242-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Institutional Review Board of Gangnam Severance Hospital approved this study (approval number: 3-2025-0008).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}